Olema Pharmaceuticals OLMA
$7.02 −$0.13 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.02 0.00%
Open$7.01
Prev close$7.15
Day range$6.88 – $7.36
Volume1.26M
Market cap$615.00M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$77.53M-69.0% YoY
Net profit-$73.60M-74.3% YoY
Diluted EPS-$0.73-49.0% YoY
Free cash flow-$48.01M-39.1% YoY
Operating cash flow-$47.11M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-69.8%
Return on assets-59.5%
Return on invested capital-74.0%
Current ratio6.12
Liabilities / assets16.4%
Cash & investments$413.77M
Total debt$3.00M
Net cash (debt)$410.77M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $77.53M | $67.18M | $57.99M | $178.70M | $50.08M |
| Selling and Admin Expenses | $9.93M | $9.39M | $8.75M | $21.00M | $6.86M |
| -General & Admin Expense | $9.93M | $9.39M | $8.75M | $21.00M | $6.86M |
| Research & Development | $67.60M | $57.79M | $49.23M | $157.70M | $43.22M |
| Operating Profit | -$77.53M | -$67.18M | -$57.99M | -$178.70M | -$50.08M |
| Net Non-Operating Interest Income (Expense) | $4.05M | $4.51M | $4.78M | $16.22M | $4.01M |
| Non-Operating Interest Income | $4.05M | $4.51M | $4.78M | $16.22M | $4.01M |
| Other Income (Expense) | -$128,000.00 | -$528,000.00 | $121,000.00 | $23,000.00 | $13,000.00 |
| Other Non-Operating Income (Expenses) | -$128,000.00 | -$528,000.00 | $121,000.00 | $23,000.00 | $13,000.00 |
| Pretax Profit | -$73.60M | -$63.20M | -$53.09M | -$162.45M | -$46.06M |
| Net Profit | -$73.60M | -$63.20M | -$53.09M | -$162.45M | -$46.06M |
| Profit from Continuing Operations | -$73.60M | -$63.20M | -$53.09M | -$162.45M | -$46.06M |
| Net Income to Parent Company | -$73.60M | -$63.20M | -$53.09M | -$162.45M | -$46.06M |
| Net Income to Common Stockholders | -$73.60M | -$63.20M | -$53.09M | -$162.45M | -$46.06M |
| Basic EPS | -$0.73 | -$0.61 | -$0.52 | -$1.87 | -$0.51 |
| Diluted EPS | -$0.73 | -$0.61 | -$0.52 | -$1.87 | -$0.51 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $441.07M | $486.58M | $530.65M | $533.43M | $533.43M |
| Total Current Assets | $423.43M | $469.88M | $513.23M | $515.45M | $515.45M |
| Cash and Cash Equivalents & Short-Term Investments | $413.77M | $461.07M | $505.35M | $505.44M | $505.44M |
| -Cash and Cash Equivalents | $47.52M | $48.60M | $52.55M | $48.30M | $48.30M |
| -Short Term Investments | $366.25M | $412.47M | $452.80M | $457.14M | $457.14M |
| Receivables | $3.37M | $3.17M | $3.35M | $4.06M | $4.06M |
| -Accrued Interest Receivable | $3.11M | $2.85M | $3.32M | $3.14M | $3.14M |
| -Taxes Receivable | $269,000.00 | $321,000.00 | $30,000.00 | $919,000.00 | $919,000.00 |
| Prepaid Assets | $6.05M | $5.43M | $3.30M | $4.37M | $4.37M |
| Other Current Assets | $235,000.00 | $206,000.00 | $1.23M | $1.59M | $1.59M |
| Total Non-Current Assets | $17.65M | $16.70M | $17.42M | $17.98M | $17.98M |
| Net PPE | $2.00M | $1.02M | $1.28M | $1.42M | $1.42M |
| -Gross PPE | $2.00M | $1.02M | $1.28M | $1.42M | $1.42M |
| Non-Current Prepaid Assets | $14.92M | $14.90M | $15.30M | $15.67M | $15.67M |
| Goodwill and Other Intangible Assets | $729,000.00 | – | – | – | – |
| -Other Intangible Assets | $729,000.00 | – | – | – | – |
| Total Liabilities | $72.23M | $56.01M | $50.17M | $54.87M | $54.87M |
| Total Current Liabilities | $69.23M | $53.01M | $47.17M | $51.80M | $51.80M |
| Payables | $1.21M | $1.67M | $3.72M | $9.25M | $9.25M |
| -Accounts Payable | $1.21M | $1.67M | $3.72M | $9.25M | $9.25M |
| Current Accrued Expenses | $60.86M | $46.21M | $40.29M | $33.17M | $33.17M |
| Short-Term Debt and Capital Lease Obligation | $356,000.00 | $660,000.00 | $956,000.00 | $1.12M | $1.12M |
| -Current Capital Lease Obligation | $356,000.00 | $660,000.00 | $956,000.00 | $1.12M | $1.12M |
| Total Non-Current Liabilities | $3.00M | $3.00M | $3.00M | $3.07M | $3.07M |
| Long Term Debt and Capital Lease Obligation | $3.00M | $3.00M | $3.00M | $3.07M | $3.07M |
| -Long Term Debt | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| -Long Term Capital Lease Obligation | $0.00 | $0.00 | $0.00 | $69,000.00 | $69,000.00 |
| Total Equity | $368.84M | $430.56M | $480.48M | $478.56M | $478.56M |
| Stockholders' Equity | $368.84M | $430.56M | $480.48M | $478.56M | $478.56M |
| Capital Stock | $8,000.00 | $8,000.00 | $8,000.00 | $8,000.00 | $8,000.00 |
| -Common Stock | $8,000.00 | $8,000.00 | $8,000.00 | $8,000.00 | $8,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.16B | $1.15B | $1.13B | $1.08B | $1.08B |
| Retained Earnings | -$787.45M | -$713.85M | -$650.65M | -$597.56M | -$597.56M |
| Gains/Losses Not Affecting Retained Earnings | -$1.59M | -$947,000.00 | -$460,000.00 | $621,000.00 | $621,000.00 |
| Other Non-Current Assets | – | $784,000.00 | $838,000.00 | $892,000.00 | $892,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$47.11M | -$45.90M | -$45.99M | -$146.72M | -$38.33M |
| Net cash flow from continuing operations | -$47.11M | -$45.90M | -$45.99M | -$146.72M | -$38.33M |
| Net Income from Continuing Operations | -$73.60M | -$63.20M | -$53.09M | -$162.45M | -$46.06M |
| Depreciation & Depletion & Amortization | $94,000.00 | $102,000.00 | $119,000.00 | $490,000.00 | $187,000.00 |
| Other Non-Cash Items | $298,000.00 | $1.57M | -$972,000.00 | -$5.12M | -$5.99M |
| Change in Working Capital | $14.79M | $5.22M | -$2.19M | $2.78M | $4.14M |
| -Change in Prepaid Assets | -$997,000.00 | $75,000.00 | $2.60M | -$5.42M | -$4.46M |
| -Change in Payables and Accrued Expense | -$458,000.00 | -$1.91M | -$5.68M | $4.60M | $5.77M |
| -Change in Other Current Assets | $52,000.00 | -$668,000.00 | -$100,000.00 | -$6.15M | -$496,000.00 |
| -Change in Other Current Liabilities | $16.19M | $7.72M | $991,000.00 | $9.74M | $3.32M |
| Net cash flow from investing | $45.60M | $40.84M | $4.53M | -$155.76M | -$162.18M |
| Net Cash Flow from Continuing Investing Activities | $45.60M | $40.84M | $4.53M | -$155.76M | -$162.18M |
| Net PPE Purchase and Sale | -$850,000.00 | – | – | $0.00 | $0.00 |
| Net Investment Purchase and Sale | $46.45M | $41.06M | $4.53M | -$155.76M | -$162.18M |
| Financing Cash Flow | $434,000.00 | $1.11M | $45.70M | $211.30M | $213.55M |
| Net Cash Flow from Continuing Financing Activities | $434,000.00 | $1.11M | $45.70M | $211.30M | $213.55M |
| Net Issuance Payments Of Debt | $0.00 | – | – | $3.00M | $0.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | $41.92M | $205.39M | $205.39M |
| Proceeds from Stock Option Exercised | $434,000.00 | -$3.54M | $8.43M | $9.42M | $8.16M |
| Ending Cash Balance | $47.52M | $48.60M | $52.55M | $48.30M | $48.30M |
| Net Change in Cash | -$1.08M | -$3.95M | $4.25M | -$91.18M | $13.04M |
| Beginning Cash Balance | $48.60M | $52.55M | $48.30M | $139.48M | $35.26M |
| Free Cash Flow | -$48.01M | -$46.12M | -$45.99M | -$146.72M | -$38.33M |
| Net Other Financing Charges | – | – | -$4.64M | -$6.51M | $0.00 |
No comments yet — be the first to weigh in on OLMA.
Sign in to join the discussion.